ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,357Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 1006

$582K Total Retail Price of All Prescriptions

Rank: 169 out of 1006

648 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 8,251 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 527 444 1 1
ATORVASTATIN CALCIUM 440 383 2 5
AMLODIPINE BESYLATE 423 358 3 4
LISINOPRIL 419 373 4 3
LEVOTHYROXINE SODIUM 342 275 5 2
HYDROCHLOROTHIAZIDE 279 245 6 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 266 213 7 38
ATENOLOL 251 247 8 13
METFORMIN HCL 245 208 9 10
METOPROLOL TARTRATE 235 213 10 7
FUROSEMIDE 216 197 11 6
PRAVASTATIN SODIUM 201 163 12 15
ZOLPIDEM TARTRATE 180 154 13 14
TRAMADOL HCL 140 100 14 35
NEXIUM 136 95 15 28
GLYBURIDE-METFORMIN HCL 130 93 R 16 192
CITALOPRAM HBR 129 92 17 24
GLYBURIDE 123 94 R 18 65
SERTRALINE HCL 123 116 18 19
AZITHROMYCIN 121 92 20 39
OMEPRAZOLE 113 83 21 9
METOPROLOL SUCCINATE 111 94 22 12
GABAPENTIN 107 89 23 20
LOSARTAN-HYDROCHLOROTHIAZIDE 106 78 24 81
ATENOLOL-CHLORTHALIDONE 105 99 25 184
WARFARIN SODIUM 98 89 26 8
CRESTOR 93 79 27 18
TRAZODONE HCL 91 67 28 21
LIPITOR 85 80 29 47
PANTOPRAZOLE SODIUM 84 82 30 32
JANUVIA 83 52 31 49
HYDROMORPHONE HCL 82 14 S2 32 153
CLOPIDOGREL 80 73 33 46
DIOVAN 78 67 34 16
CYMBALTA 78 54 34 41
BENAZEPRIL-HYDROCHLOROTHIAZIDE 77 77 36 300
ALENDRONATE SODIUM 74 53 37 29
BENAZEPRIL HCL 73 73 38 112
LOSARTAN POTASSIUM 71 62 39 22
OXYCODONE HCL-ACETAMINOPHEN 69 0 S2 40 138
HYDROCODONE-ACETAMINOPHEN 66 57 S3 41 25
ALLOPURINOL 61 51 42 31
OXYCODONE-ACETAMINOPHEN 59 38 S2 43 57
SYNTHROID 58 58 44 42
PREDNISONE 57 40 45 33
AMLODIPINE BESYLATE-BENAZEPRIL 56 49 46 77
PROMETHAZINE HCL 55 22 R 47 240
MIRTAZAPINE 54 41 48 26
CARVEDILOL 53 53 49 36
FLUTICASONE PROPIONATE 52 49 50 55
CYCLOBENZAPRINE HCL 51 23 R 51 113
MORPHINE SULFATE ER 50 0 S2 52 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.